Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
616,851
-
Shares change
-
+312,430
-
Total reported value, excl. options
-
$23,420,769
-
Value change
-
+$13,527,542
-
Number of buys
-
27
-
Number of sells
-
3
-
Price
-
$37.97
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2020
As of 30 Jun 2020 ISHARES TR - GENOMICS IMMUN (IDNA) had 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 616,851 shares of stock of the company.
Largest 10 holders included RETIREMENT CAPITAL STRATEGIES, ROYAL BANK OF CANADA, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., Sandell Asset Management Corp., JANE STREET GROUP, LLC, STIFEL FINANCIAL CORP, CITADEL ADVISORS LLC, Wharton Business Group, LLC, Sowell Financial Services LLC, and Cambridge Investment Research Advisors, Inc..
This table shows 34 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.